Clinical Trials Browser

Phase 2 × Esophagogastric Cancer × STA 9090 × Clear all

NCT01167114 2023-11-02

STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer

Phase 2 Completed

Gastrointestinal

Esophagogastric Cancer